Author Instructions Factsheet
Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
Quotation Mark
picture of Morteza Saki

Morteza Saki

Dr. Morteza Saki is a researcher within the Department of Microbiology at the Ahvaz Jundishapur University of Medical Sciences,Ahvaz, Iran.

His research focuses on the mechanisms of antimicrobial resistance in ESKAPE Pathogens, especially Klebsiella pneumoniae.

picture of Alison J Sinclair

Alison J Sinclair

BSc in Biochemistry from UCL London UK; PhD Cancer Virology at the Imperial Cancer Research Fund, London UK; post-doctoral fellowship at the European Molecular Biology Laboratory in Heidelberg, Germany, researching transcription; post-doctoral fellowship and assistant member of staff at the Ludwig Institute for Cancer Research in London, investigating a transcription factor network in Epstein-Barr virus and cell cycle regulation. Faculty School of Life Sciences at the University of Sussex, UK.

picture of Jian Song

Jian Song

Since 2016 Dr. Jian Song has been Priv.-Doz of Experimental Immunology within the Institute of Physiological Chemistry and Pathobiochemsitry at the University of Münster, Germany. He received his PhD of Molecular Medicine from Cologne University, Germany.

Dr. Song's research interests include investigating the role of basement membranes and matrix metalloproteinases in leukocyte extravasation into the brain and into the tumour microenvironment using intravital imaging and scRNA technology

picture of Anne Marie Strohecker

Anne Marie Strohecker

Assistant Professor Departments of Cancer Biology and Genetics and Surgery, The Ohio State University

We are interested in mechanisms of autophagy regulation, with a focus on discovering how to modulate the pathway for optimal therapeutic benefit. Current projects are focused on the identification of novel autophagy regulators and their functional relevance for lung tumorigenesis

picture of Ravi Tandon

Ravi Tandon

I completed my Ph.D dissertation at the University of Zurich, Switzerland where the major focus of my PhD research project was the study of endogenous feline leukemia virus (enFeLV) in cats during exogenous feline leukemia virus (FeLV) infection. My interest in retroviruses led me into the HIV research after Ph.D. My postdoctoral research project at University of California, San Francisco was on HIV immunology. On completion of my Post Doc, I joined Dr Ndhlovu’s new laboratory at the University of Hawaii to pursue studies on HIV and Aging based on my expertise and experience to address a new area of HIV research in which have interest.

Currently my research work as an Assistant Professor at JNU, New Delhi, India is focused on aging in HIV-1-infected people. Approximately one in five individuals living with HIV infection in the United States is 50 years of age or older. This proportion continues to increase as HIV incidence remains stable and potent antiretroviral therapy has reduced the morbidity and mortality associated with HIV infection. However, premature aging and non-AIDS related morbidity including cancer seem to be a new big problem in HAART era. Chronic inflammation in treated HIV-1-infected subjects seems to play an important role in non-AIDS –related complications. The main goal of my research is to investigate the mechanism of HIV mediated accelerated aging/inflammation in HAART-suppressed HIV-1 infected people.

picture of Ralph A Tripp

Ralph A Tripp

Dr. Tripp joined the University of Georgia in 2004 from the Centers of Disease Control and Prevention (CDC) in Atlanta. He is a Professor and Georgia Research Alliance Eminent Scholar working in vaccine and therapeutic studies in the Department of Infectious Diseases at UGA.

Research interests include understanding the mechanisms of immunity and disease pathogenesis associated with respiratory virus infection, and using this information to develop therapeutic protocols and vaccines that will confer long-term protective immunity.

picture of Yegor S Vassetzky

Yegor S Vassetzky

Yegor Vassetzky graduated from the Moscow State University. After a PhD thesis in molecular biology at the Engelhardt Institute of Molecular Biology in Moscow, he worked as a postdoctoral fellow in laboratories of Klaus Scherrer (Paris), Susan Gasser (Lausanne) and Marcel Méchali (Montpellier). Since 2002 he heads the laboratory of Nuclear Organization and Pathologies at Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation in cancer and neuromuscular diseases. Yegor Vassetzky is Associate Editor for Biopolymers & Cell, and member of the Editorial Board of PeerJ and Oncotarget.

picture of Shailendra Kumar Verma

Shailendra Kumar Verma

Dr. Shailendra Kumar Verma is currently a postdoctoral fellow at La Jolla Institute for Immunology, California, USA. He pursued his Ph.D. from Central Drug Research Institute, India in the field of vaccine immunology. Dr. Verma joined DRDE, and had been a scientist since 2005 to 2021. His major research area focused onto the vaccine and therapeutic development against infectious diseases. He has published more than 25 publications in peer reviewed journals of highly repute. Dr. Verma has more than 15 years of research experience in infection and immunology. His present research at La Jolla institute for Immunology is focused onto the vaccine/therapeutic development against SARS-CoV-2 and ZIKA virus.

picture of Martha Vives

Martha Vives

Full professor, Biological Sciences Department, Los Andes University. Vice dean for Research Affairs, School of Sciences. Past coordinator for the Microbiology program.

picture of Joëlle Wiels

Joëlle Wiels

Joëlle Wiels received her PhD in Genetics from Université Paris 6-Denis Diderot and then spent two years as a Post-doctoral fellow in the Division of Biochemical Oncology (Fred Hutchinson Cancer Research Center) headed by Professor Hakomori. She then moved back to France where she studied the role of glycosphingolipids in both normal and tumoral B lymphocytes. Since 1991, her main research interests include analysis of apoptotic signaling pathways and of resistance to cell death developped by B cell lymphomas. She is currently affiliated at the METSY CNRS Unit located at the Gustave Roussy Institut in Villejuif (France)

picture of Claus O Wilke

Claus O Wilke

Professor and Department Chair, Department of Integrative Biology, The University of Texas at Austin. Received his PhD in Theoretical Physics from the University of Bochum, Germany, in 1999. Postdoc at Caltech, 2000-2005.

picture of Yuri I. Wolf

Yuri I. Wolf

Lead Scientist, Koonin Group at the Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (Bethesda, Maryland).